PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ)

$0.03 0 (0%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 74

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) News Sources

Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities

08-04-2026

yahoo.com

Pacific Bay & Aurwest Sign Weaver Gold Property Definitive Option/JV Agreement

14-04-2026

yahoo.com

Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine

17-04-2026

yahoo.com

Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

20-04-2026

yahoo.com

PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) Sentiment Trend

0 25 50 75 100 80 52 78 85 08-04-2026 14-04-2026 17-04-2026 20-04-2026 #1 #2 #3 #4 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) FAQs

toggle

What is the current price of PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ)?

The current price of PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) is $0.03.


toggle

PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) absolute price change since previous trading day?

The absolute price change of PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) since the previous trading day is $0.


toggle

PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) percentage price change since previous trading day?

The percentage price change of PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) since the previous trading day is 0%.


toggle

What is the most recent average sentiment score for PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ)?

The most recent average sentiment score for PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) is 74 out of 100.


toggle

What is the most recent average sentiment for PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ)?

The most recent sentiment for PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ) is .


SEC-8K** Filing Available For PSYENCE BIOMEDICAL LTD (PBMWW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.